August 29, 2025 - 01:58

YD Bio Limited is set to embark on a new chapter as trading for its common stock and warrants is scheduled to begin on the Nasdaq Global Market on August 29, 2025. The company will be listed under the ticker symbols “YDES” for its common stock and “YDESW” for its warrants. This strategic move marks a significant milestone for YD Bio Limited, a biotechnology firm dedicated to pioneering advancements in DNA methylation-based cancer detection technologies and innovative solutions in ophthalmology.
The completion of the business combination positions YD Bio Limited for accelerated growth and market expansion, allowing it to leverage its cutting-edge technologies in a competitive landscape. With a commitment to enhancing healthcare through scientific innovation, YD Bio Limited aims to address critical challenges in cancer diagnostics and eye care. Stakeholders and investors are optimistic about the company's potential to drive advancements in these vital areas of medicine as it transitions into a publicly traded entity.
April 21, 2026 - 12:18
What smart people are saying about Tim Cook's legacy at AppleAs Tim Cook prepares to conclude his nearly 15-year tenure as Apple`s chief executive, industry observers are reflecting on the profound and complex legacy he will leave behind. Widely praised for...
April 20, 2026 - 19:35
City of Tampa to Launch Microgrant Program for Small Businesses, EntrepreneursThe City of Tampa is launching a new initiative aimed at bolstering its small business community. A dedicated kickoff event on Tuesday, April 21st will formally introduce the Microgrant Program, a...
April 20, 2026 - 02:53
A Deep Dive into Hawai‘i’s Shell Jewelry IndustryThe transformation of a seashell, once home to a marine creature, into a polished piece of jewelry is a story of artistry, culture, and increasing commercial demand. In Hawai‘i, a growing...
April 19, 2026 - 21:09
2026 Best Business Schools | Total Cost & Scholarships At P&Q’s Ranked Business SchoolsThe financial investment required for a premier MBA continues its steep ascent. Recent data reveals a significant milestone: the total cost of tuition and mandatory fees now surpasses $200,000 at...